Ignacio Gil Bazo

5.3k citations
119 papers · 4.1k · 2 hit papers · h-index 35

Impact in

    • Cancer Genomics and Diagnostics
    • MicroRNA in disease regulation
  • Oncology top 2%
    • Cancer Immunotherapy and Biomarkers
    • Lung Cancer Research Studies
    • Colorectal Cancer Treatments and Studies

Papers in

    • Lung Cancer Treatments and Mutations 32
    • Gastric Cancer Management and Outcomes 6
    • Lung Cancer Research Studies 11
    • Cancer Immunotherapy and Biomarkers 11
    • Colorectal Cancer Treatments and Studies 7

Ignacio Gil Bazo

116 papers receiving 4.0k citations

Ignacio Gil Bazo's Hit Papers

Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells 2024 · 97 citations
970+2+4Years since publication100200300400

Peers

Ignacio Gil Bazo
Comparison fields: 5 of 118
  • Cancer Research 942
  • Oncology 1.4k
  • Pulmonary and Respiratory Medicine 1.5k
  • Molecular Biology 1.5k
  • Immunology 433
Replace Jermaine I Coward with:
Jermaine I Coward Australia
Miao‐Zhen Qiu China
Christoph Salat Germany
Yutaka Yamamoto Japan
Ernest Nadal Spain
Simon J. Crabb United Kingdom
Paola Gazzaniga Italy
Jacques Gaudreault Switzerland
G. Deplanque France
Harold N Keer United States
Ignacio Gil Bazo relative to Jermaine I Coward Australia Jermaine I Coward's profile →
Citations per field
00.5×2×2.8×
Jermaine I Coward · 1×
Citations per year

Countries citing papers authored by Ignacio Gil Bazo

Since Specialization
Citations

This map shows the geographic impact of Ignacio Gil Bazo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ignacio Gil Bazo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ignacio Gil Bazo more than expected).

Fields of papers citing papers by Ignacio Gil Bazo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ignacio Gil Bazo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ignacio Gil Bazo. The network helps show where Ignacio Gil Bazo may publish in the future.

Co-authors

The 25 scholars most cited alongside Ignacio Gil Bazo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ignacio Gil Bazo Line = papers co-authored together Ignacio Gil Bazo links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 119 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial
Hit paper breakdown →
2019492
2 2018256
3 2018167
4 2014151
5 2017144
6 2015129
7 2018123
8 2020114
9 2020102
10 201698
11
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells
Hit paper breakdown →
202497
12 202192
13 202078
14 200974
15 200673
16 201473
17 200871
18 202065
19 201564
20 201063

About Ignacio Gil Bazo

Ignacio Gil Bazo is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Molecular Biology and Internal Medicine, having authored 119 papers that have together received 4.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (32 papers), Cancer Genomics and Diagnostics (13 papers), Lung Cancer Research Studies (11 papers), Cancer Immunotherapy and Biomarkers (11 papers), TGF-β signaling in diseases (8 papers), Colorectal Cancer Treatments and Studies (7 papers), Extracellular vesicles in disease (6 papers) and Gastric Cancer Management and Outcomes (6 papers). The work is most often cited by research in Cancer Research (942 citations), Oncology (1.4k citations), Pulmonary and Respiratory Medicine (1.5k citations), Molecular Biology (1.5k citations) and Immunology (433 citations). Ignacio Gil Bazo has collaborated with scholars based in Spain, United States and Belgium. Frequent co-authors include Christian Diego Rolfo, Inés López, Iosune Baraibar, Patrick Pauwels, Marco Giallombardo, Luis Estuardo Raez, Marc Peeters, Francesco Passiglia, Marta Román and Ernest Nadal. Their work appears in journals such as Clinical & Translational Oncology, Journal of Thoracic Oncology, Critical Reviews in Oncology/Hematology, Journal of Translational Medicine and Cancer Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact